Trademark: 90295385
Status Date
Monday, August 15, 2022
Filing Date
Tuesday, November 3, 2020
Published for Opposition
Tuesday, May 18, 2021
Abandoned Date
Monday, August 15, 2022
5 Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders
Aug 15, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 15, 2022
Abandonment - No Use Statement Filed
Jan 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2022
Sou Extension 1 Granted
Jan 3, 2022
Sou Extension 1 Filed
Jan 3, 2022
Teas Extension Received
Jul 13, 2021
Noa E-Mailed - Sou Required From Applicant
May 18, 2021
Official Gazette Publication Confirmation E-Mailed
May 18, 2021
Published For Opposition
Apr 28, 2021
Notification Of Notice Of Publication E-Mailed
Apr 9, 2021
Approved For Pub - Principal Register
Apr 8, 2021
Assigned To Examiner
Dec 31, 2020
New Application Office Supplied Data Entered
Nov 6, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24